• Explore /
  • Poster
  • / Prospective evaluation of low-dose ketoconazole plus hydrocortisone (HC) in chemotherapy-pretreated castration-resistant prostate cancer (CRPC) patients.

Prospective evaluation of low-dose ketoconazole plus hydrocortisone (HC) in chemotherapy-pretreated castration-resistant prostate cancer (CRPC) patients.

Abstract Poster

Authors

null

Ernest N. Lo

Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA

Ernest N. Lo , Laurel A. Beckett , Chong-xian Pan , Daniel Robles , Jennifer Marie Suga , Jacob Sands , Primo Lara Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT00895310

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 227)

DOI

10.1200/jco.2014.32.4_suppl.227

Abstract #

227

Poster Bd #

C9

Abstract Disclosures

Similar Posters

First Author: Deborah Mukherji

First Author: Syed A. Hussain

First Author: Gang Chen

First Author: Naoki Terada